22 Mar,2024
BY : Maverick Braxton
0 Comments
The United States Food and Drug Administration (FDA) has recently taken a significant step in the battle against COVID-19 by announcing the clearance of the first over-the-counter (OTC) rapid antigen test for COVID-19. This noteworthy development introduces the Flowflex COVID-19 Antigen Home Test, innovatively developed by ACON Laboratories, as a reliable, accessible testing option for the general public. The test, having successfully navigated the traditional FDA premarket review pathway, emerges as the second at-home COVID-19 test to achieve this feat. Notably, this clearance is not merely a routine authorization; it signals a remarkable advancement in the field of diagnostic tools, especially in the context of infectious diseases.
LATEST POST
Unlocking the Secrets of Scotch Thistle: Nature's Powerful Dietary Supplement
27 May 2023 | 19:50 PM
Top 10 Effective Natural Remedies for Motion Sickness Dizziness
3 Sep 2024 | 20:13 PM
The Impact of Irbesartan Hydrochlorothiazide on Quality of Life
8 Nov 2023 | 20:23 PM
Flurbiprofen: A Comprehensive Guide to Its Uses and Benefits
2 Jun 2023 | 17:52 PM
Valproic Acid vs. Other Anticonvulsants: A Comparison
12 May 2023 | 17:01 PM
Write a comment